Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2020

28.08.2020 | Research Article

Direct patient care services by community and ambulatory care pharmacists in Idaho

verfasst von: Elaine Nguyen, John T. Holmes, Radhika Narsinghani, Shanna O’Connor, Matthew W. Fuit, Lynn Thaden, Renee Robinson

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Background Pharmacists are one of the most accessible but unoptimized healthcare providers in the community. They are medication experts and have authority to independently prescribe in Idaho. Through the provision of direct patient care services (i.e., those distinct from traditional prescription dispensing functions), pharmacists have a greater opportunity to impact chronic disease prevention and management across the state. This can be done by filling gaps in community care (e.g., prescribing recommended therapy) and directly managing and preventing chronic diseases. However, current practices surrounding pharmacist-provided direct patient care services are unknown. Objective To characterize direct patient care services provided by Idaho community and ambulatory care pharmacists as well as to assess individual pharmacists’ and their work sites’ capacity and barriers in providing and expanding services. Setting Community and ambulatory care pharmacists’ work sites in Idaho. Method We administered a cross-sectional, electronic, 20-min survey to Idaho community and ambulatory care pharmacists. Main outcome measure The survey focused on collecting data on current practices, capacity, and barriers related to pharmacist-provided direct patient care services. Results The survey was completed by 280 eligible community and ambulatory care pharmacists with the majority of respondents (n = 250) offering pharmacist-provided direct patient care services. Pharmacists most often prescribed therapy for tobacco cessation (nicotine replacement, bupropion, varenicline), naloxone, and devices for patients with diabetes. Top barriers to individual pharmacists providing services were dispensing load and workload while top barriers to work sites (e.g., environment) were reimbursement/billing, number of available staff, and workflow. Conclusion Idaho community and ambulatory care pharmacists currently offer direct patient care services to patients across the state, but face barriers in providing and increasing services offered.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabet Care. 2018;41(5):917–28.CrossRef American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabet Care. 2018;41(5):917–28.CrossRef
3.
Zurück zum Zitat Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–528.CrossRefPubMed Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–528.CrossRefPubMed
7.
Zurück zum Zitat Yap D. Idaho pharmacists can prescribe more than 20 categories of medications. Pharmacy Today. 2018;24(10):44–5.CrossRef Yap D. Idaho pharmacists can prescribe more than 20 categories of medications. Pharmacy Today. 2018;24(10):44–5.CrossRef
8.
Zurück zum Zitat Adams AJ, Weaver KK. The continuum of pharmacist prescriptive authority. Ann Pharmacother. 2016;50(9):778–84.CrossRefPubMed Adams AJ, Weaver KK. The continuum of pharmacist prescriptive authority. Ann Pharmacother. 2016;50(9):778–84.CrossRefPubMed
13.
Zurück zum Zitat Sabater-Hernandez D, Sabater-Galindo M, Fernandez-Llimos F, Rotta I, Hossain LN, Durks D, et al. A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease. J Manag Care Spec Pharm. 2016;22(6):699–713.PubMed Sabater-Hernandez D, Sabater-Galindo M, Fernandez-Llimos F, Rotta I, Hossain LN, Durks D, et al. A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease. J Manag Care Spec Pharm. 2016;22(6):699–713.PubMed
14.
Zurück zum Zitat Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsey E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48(10):923–33.CrossRefPubMed Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsey E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48(10):923–33.CrossRefPubMed
15.
Zurück zum Zitat Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabet Care. 2012;35(12):2706–17.CrossRef Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabet Care. 2012;35(12):2706–17.CrossRef
16.
Zurück zum Zitat Charrois TL, Zolezzi M, Koshman SL, Pearson G, Makowsky M, Durect T, et al. A systematic review of the evidence for pharmacist care of patient with dyslipidemia. Pharmacotherapy. 2012;32(3):222–33.CrossRefPubMed Charrois TL, Zolezzi M, Koshman SL, Pearson G, Makowsky M, Durect T, et al. A systematic review of the evidence for pharmacist care of patient with dyslipidemia. Pharmacotherapy. 2012;32(3):222–33.CrossRefPubMed
17.
Zurück zum Zitat Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78(6):1238–47.CrossRefPubMedPubMedCentral Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78(6):1238–47.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Jokanovic N, Tan EC, Sudhakaran S, Kirkpatrick CM, Dooley MJ, Ryan-Atwood TE, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–85.CrossRefPubMed Jokanovic N, Tan EC, Sudhakaran S, Kirkpatrick CM, Dooley MJ, Ryan-Atwood TE, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–85.CrossRefPubMed
23.
Zurück zum Zitat American Society of Health-System Pharmacists. ASHP statement on the role of health-system pharmacists in public health. Am J Health-Syst Pharm. 2008;65(5):462–7.CrossRef American Society of Health-System Pharmacists. ASHP statement on the role of health-system pharmacists in public health. Am J Health-Syst Pharm. 2008;65(5):462–7.CrossRef
24.
Zurück zum Zitat Gebbie K, Merrill J, Tilson HH. The public health workforce. Health Aff. 2002;21(6):57–67.CrossRef Gebbie K, Merrill J, Tilson HH. The public health workforce. Health Aff. 2002;21(6):57–67.CrossRef
25.
Zurück zum Zitat Watson T, Hughes C. Pharmacists and harm reduction: a review of current practices and attitudes. Can Pharm J. 2012;145(3):124–7.CrossRef Watson T, Hughes C. Pharmacists and harm reduction: a review of current practices and attitudes. Can Pharm J. 2012;145(3):124–7.CrossRef
26.
Zurück zum Zitat American Society of Health-System Pharmacists. ASHP guidelines on the pharmacist’s role in immunization. Am J Health-Syst Pharm. 2003;60(13):1371–7.CrossRef American Society of Health-System Pharmacists. ASHP guidelines on the pharmacist’s role in immunization. Am J Health-Syst Pharm. 2003;60(13):1371–7.CrossRef
28.
Zurück zum Zitat Reynolds V, Causey H, McKee J, Reinstein V, Muzyk A. The role of pharmacists in the opioid epidemic: an examination of pharmacist-focused initiatives across the United and North Carolina. N C Med J. 2017;78(3):202–5.PubMed Reynolds V, Causey H, McKee J, Reinstein V, Muzyk A. The role of pharmacists in the opioid epidemic: an examination of pharmacist-focused initiatives across the United and North Carolina. N C Med J. 2017;78(3):202–5.PubMed
29.
Zurück zum Zitat Compton WM, Jones CM, Stein JB, Wargo EM. Promising roles for pharmacists in addressing the U.S. opioid crisis. Res Social Adm Pharm. 2019;15(8):910–6.CrossRefPubMed Compton WM, Jones CM, Stein JB, Wargo EM. Promising roles for pharmacists in addressing the U.S. opioid crisis. Res Social Adm Pharm. 2019;15(8):910–6.CrossRefPubMed
30.
Zurück zum Zitat Thaku R, Frey M, Chewning B. Pharmacist services in the opioid crisis: current practices and scope in the United States. Pharmacy. 2019;7(2):pii E60.CrossRef Thaku R, Frey M, Chewning B. Pharmacist services in the opioid crisis: current practices and scope in the United States. Pharmacy. 2019;7(2):pii E60.CrossRef
36.
Zurück zum Zitat Wadsworth TG, Hibbard A, Robinson R, Biddle MA, Nguyen E, O’Connor S, et al. Pharmacist medical provider status in Alaska, the last frontier. J Am Pharm Assoc. 2020;S1544–3191(20):30155-2. Wadsworth TG, Hibbard A, Robinson R, Biddle MA, Nguyen E, O’Connor S, et al. Pharmacist medical provider status in Alaska, the last frontier. J Am Pharm Assoc. 2020;S1544–3191(20):30155-2.
38.
Zurück zum Zitat Spiro S. Digital transformation of pharmacists’ clinical services. J Am Pharm Assoc. 2019;59(2S):S8–12.CrossRef Spiro S. Digital transformation of pharmacists’ clinical services. J Am Pharm Assoc. 2019;59(2S):S8–12.CrossRef
39.
Zurück zum Zitat Nguyen E, Holmes JT. Pharmacist-provided services: barriers to demonstrating value. J Am Pharm Assoc. 2019;59(1):117–20.CrossRef Nguyen E, Holmes JT. Pharmacist-provided services: barriers to demonstrating value. J Am Pharm Assoc. 2019;59(1):117–20.CrossRef
Metadaten
Titel
Direct patient care services by community and ambulatory care pharmacists in Idaho
verfasst von
Elaine Nguyen
John T. Holmes
Radhika Narsinghani
Shanna O’Connor
Matthew W. Fuit
Lynn Thaden
Renee Robinson
Publikationsdatum
28.08.2020
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2020
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01130-0

Weitere Artikel der Ausgabe 6/2020

International Journal of Clinical Pharmacy 6/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.